This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.

Research Alert: May 18, 2017

Changes in the Supply of Physicians with a DEA DATA Waiver to Prescribe Buprenorphine for Opioid Use Disorder

The opioid abuse epidemic is a significant public health problem today. Rural populations face challenges in accessing treatment. More than half of rural counties nationally lack a physician with a Drug Enforcement Agency (DEA) waiver to prescribe buprenorphine, a medication-assisted treatment that can be provided in an office based setting.

Contact Information:

Holly Andrilla, MS
WWAMI Rural Health Research Center
Phone: 206.685.6680
hollya@fammed.washington.edu

Additional Resources of Interest: